pcNewsWire – CBD Med Research Corp. (TSX-V: CBM.H) intends to close a non-brokered private placement of up to 3,333,333 common shares at a price of $0.15 per share for gross proceeds of up to $500,000.
News Release
CBD MED RESEARCH PROCEEDS WITH PRIVATE PLACEMENT
June 29, 2017 – Vancouver, British Columbia – CBD Med Research Corp. (TSXV: CBM.H) (the “Company”) announces that further to its news release dated May 10, 2017, the Company is proceeding with a non-brokered private placement of up to 3,333,333 common shares at a price of $0.15 per share for gross proceeds of up to $500,000. The Company may pay a finder’s fee of 6% on all or a portion of the private placement.
Completion of the private placement is subject to approval of the TSX Venture Exchange.
ON BEHALF OF THE BOARD
“Gary Zak”
Gary F. Zak, Chief Executive Officer
For further information, please contact: Gary Zak gzak1@shaw.ca or 604-802-7551
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release